Benzodiazepines Contraindications
Benzodiazepines are absolutely contraindicated in patients with myasthenia gravis, severe respiratory insufficiency, severe hepatic insufficiency, sleep apnea syndrome, and acute narrow-angle glaucoma, according to FDA labeling. 1
Absolute Contraindications
The following conditions represent absolute contraindications where benzodiazepines must not be prescribed:
- Myasthenia gravis - benzodiazepines can exacerbate muscle weakness 1
- Severe respiratory insufficiency - risk of life-threatening respiratory depression 1
- Severe hepatic insufficiency - impaired drug clearance leads to accumulation and toxicity 1
- Sleep apnea syndrome - benzodiazepines worsen respiratory depression during sleep 1
- Acute narrow-angle glaucoma - benzodiazepines are contraindicated, though may be used in open-angle glaucoma with appropriate therapy 1
- Known hypersensitivity to benzodiazepines 1
- Pediatric patients under 6 months of age - insufficient clinical experience 1
Relative Contraindications and High-Risk Situations
Substance Use Disorders
The traditional position that benzodiazepines are absolutely contraindicated in patients with substance abuse history lacks strong empirical justification, but extreme caution is warranted. 1, 2
- Benzodiazepines should be used with extreme caution in patients with a history of alcohol or drug abuse 1
- Patients with substance use disorders who receive prescribed benzodiazepines have a 15% risk of developing benzodiazepine abuse compared to 6% in those not prescribed benzodiazepines 3
- Most benzodiazepine abusers concurrently abuse other substances; benzodiazepines are typically a secondary drug of abuse 2, 4
- Avoid benzodiazepines in patients with dependent personality types or active polysubstance abuse 5
- Co-occurring alcohol or benzodiazepine abuse is an indication for specialist referral 6
Respiratory Conditions
- Chronic respiratory insufficiency requires lower doses due to risk of respiratory depression 1
- Central sleep apnea is a risk factor for opioid overdose when benzodiazepines are combined with opioids 6
Hepatic Impairment
- Benzodiazepine clearance is reduced in hepatic dysfunction, requiring dose reduction 6
- Lorazepam, oxazepam, and temazepam are preferred in liver disease due to direct glucuronidation metabolism 7
Neuropsychiatric Conditions
- Avoid in uremic encephalopathy or delirium - benzodiazepines worsen the underlying condition and prevent accurate clinical assessment 8
- Patients with dementia experience greater risks of sedation, falls, cognitive impairment, and prolonged drug effects 8
- Psychiatric and paradoxical reactions (agitation, aggression) occur more commonly in children and elderly patients 1, 7
Geriatric Population
Elderly patients represent a high-risk population requiring special precautions, not absolute contraindication:
- Greater risks of sedation, falls, cognitive impairment, and prolonged drug effects 8
- Start with lowest effective doses (e.g., 2 mg diazepam once or twice daily initially) 1
- Benzodiazepines cause cognitive impairment, reduced mobility, unsafe driving skills, and decline in functional independence 8
Critical Drug Interactions (Relative Contraindications)
Opioid Co-Administration
Concomitant use of benzodiazepines with opioids can result in profound sedation, respiratory depression, coma, and death through cumulative and synergistic effects. 8
- The combination increases overdose risk dramatically 6
- If co-prescription is unavoidable, use lowest effective doses of both agents and monitor closely 6
- Patients should not drive or operate machinery until effects are determined 1
Other CNS Depressants
- Avoid combining with alcohol - additive psychomotor impairment and respiratory depression 7, 1
- Phenothiazines, narcotics, barbiturates, MAO inhibitors potentiate benzodiazepine effects 1
- Fatalities reported with concurrent use of benzodiazepines and high-dose olanzapine due to oversedation and respiratory depression 9, 7, 8
Duration-Related Contraindications
Long-term benzodiazepine use (>2-4 weeks) should be considered a relative contraindication in most patients:
- Prescriptions should ideally be limited to a few days, occasional/intermittent use, or courses not exceeding 2-4 weeks 8, 10
- Approximately 50% of patients prescribed benzodiazepines continue use for at least 12 months despite guidelines recommending short-term use only 8
- Regular use leads to tolerance, addiction, depression, and cognitive impairment 7
- Withdrawal reactions can be life-threatening, including seizures 1
Common Pitfalls to Avoid
- Do not assume short-acting benzodiazepines are safer - active metabolites still accumulate, especially in renal failure 8
- Never abruptly discontinue after prolonged use - use gradual taper over months to prevent withdrawal seizures 6, 1
- Do not use to manage delirium or encephalopathy itself - worsens the condition 8
- Avoid in patients requiring opioids for pain control unless absolutely necessary with enhanced monitoring 6
- Do not prescribe without considering psychiatric comorbidities - depression with suicidal tendencies requires protective measures 1